Ipsilateral breast tumor recurrence: Is there any evidence for benefit of further systemic therapy?

Breast Journal

Volumn 15, Issue 3, 2009, Pages 268-278

  Sirohi, Bhawna ^a   Leary, Alexandra ^a   Johnston, Stephen R D ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Ipsilateral breast tumor recurrence; Systemic therapy

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; BCG VACCINE; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; INTERFERON; LAPATINIB; LETROZOLE; METHOTREXATE; PROGESTERONE RECEPTOR; TAMOXIFEN; TRASTUZUMAB; VINCRISTINE;

ADJUVANT THERAPY; BREAST CANCER; BREAST SURGERY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER IMMUNOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CLINICAL PRACTICE; DRUG EFFICACY; DRUG TARGETING; HISTOLOGY; HUMAN; IPSILATERAL BREAST TUMOR RECURRENCE; MASTECTOMY; METASTASIS; MULTIPLE CYCLE TREATMENT; ONCOGENE NEU; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; TREATMENT OUTCOME;

BREAST NEOPLASMS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III AS TOPIC; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY, ADJUVANT; WOMEN'S HEALTH;

EID: 65549118350     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2009.00716.x     Document Type: Review

References (80)

1. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002 347 : 1233 41. (Pubitemid 35176242)
2. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002 347 : 1227 32. (Pubitemid 35176241)
3. van Dongen J, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and treatment of cancer 10801 trial. J Natl Cancer Inst 2000 92 : 1143 50.
4. Forrest AP, Stewart HJ, Everington D, et al. Randomized controlled trial of conservation therapy for breast cancer : 6-year analysis of the Scottish trial. Scottish Cancer Trials breast group. Lancet 1996 348 : 708 13.
5. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer 2003 98 : 697 702. (Pubitemid 36959264)
6. Fisher B, Bryant J, Wolmark N, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998 16 : 2672 85. (Pubitemid 28363030)
7. Van der Hage JA, van de Velde CJ, Julien JP, et al. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol 2001 19 : 4224 37. (Pubitemid 33081640)
8. Smith IE, Lipton L. Preoperative/neoadjuvant medical therapy for early breast cancer. Lancer Oncol 2001 2 : 561 70. (Pubitemid 33586869)
9. Rouzier R, Extra JM, Carton M, et al. Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumour recurrence after breast-conserving surgery. J Clin Oncol 2001 19 : 3828 35. (Pubitemid 32880061)
10. Fowble B, Solin L, Schultz D, Rubenstein J, Goodman RL. Breast recurrence following conservative surgery and radiation. Patterns of failure, prognosis and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990 19 : 833 42. (Pubitemid 20345149)
11. Lichter A, Lippman M, Danforth D, et al. Mastectomy versus breast-conserving therapy in the treatment of stage I and II carcinoma of breast: a randomized trial of the National Cancer Institute. J Clin Oncol 1992 10 : 976 83.
12. Whelan T, Clark R, Roberts R, et al. Ipsilateral breast tumor recurrence postlumpectomy is predictive of subsequent mortality: results from a randomized trial. Int J Radiat Oncol Biol Phys 1994 30 : 11 6. (Pubitemid 24291108)
13. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995 333 : 1456 61.
14. Arriagada R, Le M, Rochard F, et al. Conservative treatment versus mastectomy in early stage breast cancer: patterns of failure after 15 years of follow-up data. J Clin Oncol 1996 14 : 1558 64. (Pubitemid 26134214)
15. Recht A, Connolly JL, Schnitt SJ, et al. The effect of young age on tumor recurrence in the treated breast after conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1988 14 : 3 10. (Pubitemid 18059122)
16. Komoike Y, Akiyama F, Lino Y, et al. Analysis of Ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors. Breast Cancer 2005 12 : 104 11.
17. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 1995 87 : 19 27.
18. Kasumi F, Takahashi K, Nishimura S, et al. CIH-Tokyo experience with breast-conserving surgery without radiotherapy; 6.5 year follow-up results of 1462 patients. Breast J 2006 12 : S181 90. (Pubitemid 44337466)
19. Smith TE, Lee D, Turner BC, et al. True recurrence versus new primary Ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int J Radiat Oncol Biol Phys 2000 48 : 1281 9.
20. Krauss DJ, Kestin LL, Mitchell C, Martinez AA, Vicini FA. Changes in temporal patterns of local failure after breast conserving therapy and their prognostic implications. Int J Radiat Oncol Biol Phys 2004 60 : 731 40. (Pubitemid 39311752)
21. Haffty BG, Carter D, Flynn SD, et al. Local recurrence new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. Int J Radiat Oncol Biol Phys 1993 27 : 575 83. (Pubitemid 23331124)
22. Fisher B, Anderson S, Fisher ER, et al. Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 1991 338 : 327 31.
23. Komoike Y, Akiyana F, Lino Y, et al. Ipsilateral breast tumor recurrence (IBTR) after breast conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 2006 106 : 35 41. (Pubitemid 43032546)
24. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after Ipsilateral breast tumor recurrence and loco regional recurrences in five national surgical adjuvant breast and bowel project node positive adjuvant breast cancer trials. J Clin Oncol 2006 24 : 2028 36. (Pubitemid 46622111)
25. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996 88 : 1659 64. (Pubitemid 26384812)
26. Freedamn GM, Fawble B. Local recurrence after mastectomy or breast conserving surgery and radiation. Oncology 2000 14 : 1561 81.
27. Touboul E, Buffat L, Belkacemi Y, et al. Local recurrences and distant metastases after breast conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 2000 46 : 683 4.
28. Fowble BL, Schultz DJ, Overmoyer B, et al. The influence of young age on outcome in early stage breast cancer. Int J Radiat Oncol Biol Phys 1994 30 : 23 33. (Pubitemid 24291110)
29. Arriagada R, Le MG, Contesso G, et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2002 13 : 1404 13.
30. Early Breast Cancer Trialists Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomized trials. Lancet 2000 355 : 1757 70.
31. Vernonesi U, Luni A, Del Veccio M, et al. Radiotherapy after breast preserving surgery in woman with localized cancer of the breast. N Engl J Med 1993 328 : 1587 91.
32. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer. Ann Oncol 2005 16 : 1569 83. (Pubitemid 41683592)
33. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol 2001 19 : 1688 97. (Pubitemid 32230869)
34. Voogd AC, Tlenhoven GV, Peterse HL, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma. Detection, treatment and outcome in 266 patients. Cancer 1999 85 : 437 46. (Pubitemid 29051300)
35. Livi L, Paiar F, Meldolesi E, et al. Tubular carcinoma of the breast: Outcome and loco-regional recurrence in 307 patients. Eur J Surg Oncol 2005 31 : 9 12. (Pubitemid 40103918)
36. Kitchen PR, Smith HJ, Henderson MA, et al. Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy. ANZ J Surg 2001 71 : 27 31. (Pubitemid 33754937)
37. Gentilini O, Intra M, Gandini S, et al. Ipsilateral breast tumour reappearance in patients treated with conservative surgery after primary chemotherapy. The role of surgical margins on outcome. J Surg Oncol 2006 94 : 375 9. (Pubitemid 44465340)
38. Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 2004 96 : 115 21. (Pubitemid 38195902)
39. Clark M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomized trials. Lancet 2005 366 : 2087 40.
40. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001 12 : 997 1003. (Pubitemid 32725776)
41. Malmstrom P, Holmberg L, Anderson H, et al. Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening. Eur J Cancer 2003 39 : 1690 7. (Pubitemid 36897605)
42. Renton SC, Gazet JC, Ford HT, Corbishley C, Sutcliffe R. The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol 1996 22 : 17 22. (Pubitemid 26121686)
43. Fisher B, Bryant J, Dignam JJ, et al. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 2002 20 : 4141 9. (Pubitemid 35191016)
44. Hughes KS, Schnaper L, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 2004 351 : 971 7. (Pubitemid 39166260)
45. Fyles A, McCready D, Manchul L, et al. Preliminary results of a randomized study of tamoxifen ± breast radiation in T1/2 N0 disease in women over 50 years of age. N Engl J Med 2004 351 : 963 70.
46. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999 17 : 2326 33. (Pubitemid 29368230)
47. Lim M, Bellon JR, Gelman R, et al. A prospective study of conservative surgery without radiation therapy in select patients with stage I breast cancer. Int J Radiat Oncol Biol Phys 2006 65 : 1149 54. (Pubitemid 43914212)
48. Sartor C, Peterson B, Woolf S, et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node positive breast cancer: Cancer and Leukemia group B9344. J Clin Oncol 2005 23 : 30 40. (Pubitemid 41709334)
49. Buchholz TA, Tucker SL, Erwin J, et al. Impact of systemic treatment on local control for patients with lymph node negative breast cancer treated with breast-conservation therapy. J Clin Oncol 2001 19 : 2240 6. (Pubitemid 32372325)
50. Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs salvage breast conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 2005 63 : 845 51. (Pubitemid 41400074)
51. Shen J, Hunt KK, Mirza NQ, et al. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 2005 104 : 479 90. (Pubitemid 41022803)
52. Doyle T, Schultz DJ, Peters C, Harris E, Solin LJ. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 2001 51 : 74 80. (Pubitemid 32758864)
53. Galper S, Blood E, Gelman R, et al. Prognosis after local recurrence after conservation surgery and radiation for early stage breast cancer. Int J Radiat Oncol Biol Phys 2005 61 : 348 57. (Pubitemid 40164426)
54. Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 1996 14 : 52 7. (Pubitemid 26019996)
55. Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM. Results of wide excision for mammary recurrence after breast-conserving surgery. Cancer 1988 61 : 1969 72. (Pubitemid 18088994)
56. Chagpar A, Langstein HN, Kronowitz SJ, et al. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast conservation. Am J Surg 2004 187 : 164 9. (Pubitemid 38183428)
57. Salvadori B, Marubini E, Miceri R, et al. Reoperation for locally recurrent brest cancer in patients previously treated with conservative surgery. Br J Surg 1999 86 : 84 7. (Pubitemid 29051913)
58. Kurtz JM, Jacquemier J, Amalric R, et al. Is breast conservation after local recurrence feasible? Eur J Cancer 1991 27 : 240 4.
59. Dalberg K, Mattsson A, Sandelin K, Rutqvist LE. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat 1998 49 : 69 78. (Pubitemid 28279583)
60. Cajucom CC, Tsangaris TN, Nemoto T, Driscoll D, Penetrante RB, Holyoke ED. Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer 1993 71 : 1774 9. (Pubitemid 23067393)
61. Resch A, Fellner C, Mock U, et al. Locally recurrent breast cancer: Pulse dose rate brachytherapy for repeat irradiation following lumpectomy. A second chance to preserve the breast. Radiology 2002 225 : 713 8. (Pubitemid 35387106)
62. Maulard C, Housset M, Brunel P, et al. Use of perioperative or split course interstitial brachytherapy techniques for salvage irradiation of isolated local recurrences after conservative management of breast cancer. Am J Clin Oncol 1995 18 : 348 52.
63. Boccardo F, Rubagotti A, Puntoni M, et al. Switching to anastrazole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 2005 23 : 5138 47. (Pubitemid 46224022)
64. Coombes RC, Kilburn LS, Snowdon CF, et al. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial. Lancet 2007 369 : 559 70.
65. Jakesz R, Jonat W, Gnant M, et al. Switching of postmenopausal women with endocrine responsive early breast cancer to anastrazole after 2 years adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 2005 366 : 455 62. (Pubitemid 41111693)
66. Jakesz R, Gnant M, Greil R, et al. The benefits of sequencing adjuvant tamoxifen and anastrazole in postmenopausal women with hormone responsive early breast cancer: 5 year analysis of ABCSG Trial 8. Breast Cancer Res Treat 2005 94 : S10 (Abstract).
67. Goss PE, Ingle JN, Martino S, et al. A randomized trial of letrozole in postmenopausal women after 5 years of tamoxifen therapy for early stage breast cancer. N Engl J Med 2003 349 : 1793 802. (Pubitemid 37362955)
68. Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multi-center study comparing systemic treatment with observation after excision and radiation -Swiss group for clinical cancer research. J Clin Oncol 1994 12 : 2071 7. (Pubitemid 24356023)
69. Waeber M, Castiglione-Gertsch M, et al. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: Definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 2003 14 : 1215 21. (Pubitemid 37039046)
70. Halverson KJ, Perez CA, Kuske RR, Garcia DM, Simpson JR, Fineberg B. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 1992 15 : 93 101.
71. Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 1996 14 : 2738 46. (Pubitemid 26329660)
72. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer. Cochrane Database Syst Rev 2001 1 : CD000486.
73. Bertelli G, Garrone O, Merlano M, et al. Sequential treatment with exemestane and non-steroidal aromatase inhibitors in advanced breast cancer. Oncology 2005 69 : 471 7. (Pubitemid 41160965)
74. Buzdar AU, Blumenschein GR, Smith TL, et al. Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED). J Surg Oncol 1979 12 : 27 40.
75. Janjan NA, McNeese MD, Buzdar AU, Montague ED, Oswald MJ. Management of locoregional recurrent breast cancer. Cancer 1986 58 : 1552 6. (Pubitemid 16016843)
76. Olson CE, Ansfield FJ, Richards MJ, Ramirez G, Davis HL. Review of local soft tissue recurrence of breast cancer irradiated with and without actinomycin-D. Cancer 1977 39 : 1981 3. (Pubitemid 8129032)
77. Fentiman IS, Balkwill FR, Cuzick J, Hayward JL, Rubens RD. A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence. Eur J Surg Oncol 1987 13 : 425 8. (Pubitemid 17157342)
78. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987 235 : 177 82. (Pubitemid 17231334)
79. Smith I, Proctor M, Gelber RD, et al. 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomized controlled trial. Lancet 2007 369 : 29 36. (Pubitemid 46039831)
80. Geyer CE, Forster J, Lindquist D, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 2006 355 : 2733 43. (Pubitemid 46021510)